🇺🇸 FDA

Intelligence · Patent portfolio

SANGAMO THERAPEUTICS Patents

Full USPTO pharma patent portfolio for SANGAMO THERAPEUTICS — grant dates, expiration, and drug cross-links.

Patents
192
Expiring ≤24m
7

Quick answer

SANGAMO THERAPEUTICS has 192 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 7 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 4

  1. US 9943565

    Methods and compositions for treating trinucleotide repeat disorders

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9937207

    Targeted disruption of T cell receptor genes using talens

    Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9914940

    Targeted integration into the PPP1R12C locus

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9877988

    Method of treating lysosomal storage diseases using nucleases and a transgene

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9833479

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9834787

    Targeted integration into stem cells

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9816074

    Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9782437

    Methods and compositions for targeted cleavage and recombination

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9783827

    DNA-binding proteins and uses thereof

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9777281

    Methods and compositions for regulation of transgene expression

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9771403

    Methods and compositions for treating hemophilia

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9757420

    Gene editing for HIV gene therapy

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9717759

    Modification of CXCR4 using engineered zinc finger proteins

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9650648

    Methods and compositions for treatment of a genetic condition

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9631187

    Methods and compositions for gene correction

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9631186

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9629930

    Methods and compositions for treating hemophilia B

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9624498

    Methods and compositions for regulation of zinc finger protein expression

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9624509

    Modulation of stem cells using zinc finger proteins

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9616090

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9597357

    T cell modifying compounds and uses thereof

    Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9574211

    Methods and compositions for prevention or treatment of a disease

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9566352

    Methods and compositions for inhibiting viral entry into cells

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9567609

    Compositions for linking DNA-binding domains and cleavage domains

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9567573

    Genome editing of a Rosa locus using nucleases

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9499597

    Methods and compositions for treating Huntington's disease

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9491934

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9493750

    DNA-binding proteins and uses thereof

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9434776

    Methods and compositions for gene inactivation

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9402879

    Methods and compositions for modulating PD1

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9394545

    Methods and compositions for regulation of transgene expression

    Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9394531

    Compositions for linking DNA-binding domains and cleavage domains

    Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9322005

    DNA-binding proteins and uses thereof

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9289451

    Methods and compositions for targeted cleavage and recombination

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9267123

    Methods and compositions for gene correction

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9267154

    Targeted integration into the PPP1R12C locus

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9260726

    Targeted integration and expression on exogenous nucleic acid sequences

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9255250

    Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene

    Expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9238803

    Modified zinc finger binding proteins

    Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9234016

    Engineered zinc finger proteins for treating trinucleotide repeat disorders

    Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9234187

    Modified zinc finger binding proteins

    Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9234188

    Modified zinc finger binding proteins

    Expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9217026

    Method of inactivating a glucocorticoid receptor gene in an isolated cell

    Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9200266

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9175280

    Methods and compositions for treating hemophilia B

    Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9163245

    Compositions for linking zinc finger modules

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9161995

    Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9150847

    Methods and compositions for regulation of transgene expression

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does SANGAMO THERAPEUTICS have?

192 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do SANGAMO THERAPEUTICS patents expire?

7 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.